The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
The Quest for Omnichannel: Is Medical Affairs Ready?
Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
A Guide to Creating a Robust Patient Engagement Strategy
Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...
Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward
Ensuring that your organization embraces DE & I training is important for cultivating a strong...
Why Is It Important to Include Patients as Peer Reviewers
Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...